HomePLSE • NASDAQ
Pulse Biosciences Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 20.28M | 72.91% |
Net income | -19.17M | -68.39% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -20.00M | -75.03% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 106.35M | 305.97% |
Total assets | 120.25M | 197.44% |
Total liabilities | 15.76M | 17.13% |
Total equity | 104.49M | — |
Shares outstanding | 67.28M | — |
Price to book | 11.33 | — |
Return on assets | -39.97% | — |
Return on capital | -42.28% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -19.17M | -68.39% |
Cash from operations | -12.81M | -52.56% |
Cash from investing | -123.00K | -324.14% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -12.93M | -48.81% |
Free cash flow | -6.35M | -49.36% |
Previous close
$17.56
Day range
$17.27 - $18.06
Year range
$13.77 - $25.00
Market cap
1.17B USD
Avg Volume
220.77K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Headquarters
Website
Employees
75
